Skip to content

The Effect of Locally Delivered Ciclosporin as an Adjunct to Healing After Treatment of Periodontal Pockets

The Effect of Locally Delivered Ciclosporin as an Adjunct to Healing After Treatment of Periodontal Pockets

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02366585
Enrollment
23
Registered
2015-02-19
Start date
2015-03-31
Completion date
2016-10-31
Last updated
2017-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Brief summary

The main purpose of the trial is to investigate the effect of locally delivered ciclosporin as an adjunct to non-surgical mechanical debridement in the treatment of chronic periodontitis and to compare it to mechanical debridement alone.

Interventions

DRUGCiclosporin

Ciclosporin gel applied to two periodontal pockets

Sponsors

PerioC Limited
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients in good general health * 2 pairs of contralateral interproximal periodontal sites with probing depths of ≥7mm in single-rooted teeth not associated with furcations or root furrows.The test sites should have a distance of at least two teeth to the control sites. * Teeth selected should have a vital pulp as determined by thermal or electric stimulation

Exclusion criteria

* Patients already included in other clinical trials involving therapeutic intervention (either medical or dental) * Periodontal treatment during the last 6 months * Antibiotic treatment 6 months prior to the start of the trial * Antibiotic prophylaxis required for dental treatment * Patients with acute infectious lesions in the areas of intended treatment * Regular anti-inflammatory medication * Known history of ciclosporin allergy * Ongoing medication that may affect the clinical features of periodontitis * Patients who are smokers * Patients that are immuno-compromized or on immunosuppressive medication * Patients who are pregnant or lactating

Design outcomes

Primary

MeasureTime frameDescription
Probing pocket depth (PPD)3 monthsMean change in probing pocket depth (PPD) from baseline to 3-month examination
Bleeding on Probing (BoP)3 monthsChange in BoP (measured as present or absent) from baseline to 3-month examination

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026